Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women

This publication has 27 references indexed in Scilit:

• Tibolone is not converted by human aromatase to 7α-methyl-17α-ethynylestradiol (7α-MEE):
  Steroids, 2003
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Hormonal regulation of apoptosis in breast cells and tissues
  Steroids, 2000
• A double‐blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms
  BJOG: An International Journal of Obstetrics and Gynaecology, 1998
• Mammographic Changes in Women Receiving Tibolone Therapy
  Fertility and Sterility, 1998
• Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
  The Lancet, 1997
• The effect of tibolone on proliferation, differentiation and apoptosis in normal breast cells
  Gynecological Endocrinology, 1997
• Mammographic Features and Breast Cancer Risk: Effects With Time, Age, and Menopause Status
  JNCI Journal of the National Cancer Institute, 1995
• Effects of progestagens and Org OD14 in in vitro and in vivo tumor models
  The Journal of Steroid Biochemistry and Molecular Biology, 1994
• Breast patterns as an index of risk for developing breast cancer
  American Journal of Roentgenology, 1976